HIGHBRIDGE CAPITAL MANAGEMENT LLC - PERNIX THERAPEUTICS HLDGS IN ownership

PERNIX THERAPEUTICS HLDGS IN's ticker is and the CUSIP is 71426VAK4. A total of 13 filers reported holding PERNIX THERAPEUTICS HLDGS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
HIGHBRIDGE CAPITAL MANAGEMENT LLC ownership history of PERNIX THERAPEUTICS HLDGS IN
ValueSharesWeighting
Q2 2017$14,367,000
+0.9%
51,775,0000.0%0.21%
+3.4%
Q1 2017$14,238,000
+7.8%
51,775,0000.0%0.21%
-11.9%
Q4 2016$13,203,000
+33.1%
51,775,000
+53.3%
0.24%
+49.7%
Q3 2016$9,921,000
+23.0%
33,775,0000.0%0.16%
+19.8%
Q2 2016$8,063,00033,775,0000.13%
Other shareholders
PERNIX THERAPEUTICS HLDGS IN shareholders Q3 2017
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 22,760,000$6,745,0001.39%
Telemetry Investments, L.L.C. 9,000,000$1,530,0000.69%
Broadfin Capital, LLC 15,500,000$4,049,0000.49%
Avoro Capital Advisors LLC 6,000,000$1,651,0000.21%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 51,775,000$14,238,0000.21%
Aisling Capital LLC 2,500,000$688,0000.12%
Bruce & Co., Inc. 2,000,000$500,0000.12%
TENOR CAPITAL MANAGEMENT Co., L.P. 2,000,000$582,0000.06%
BARINGS LLC 15,000,000$2,550,0000.03%
ZAZOVE ASSOCIATES LLC 2,000,000$550,0000.03%
View complete list of PERNIX THERAPEUTICS HLDGS IN shareholders